Business Context and Reporting Period
This Form 6-K filing by Willis Group Holdings Limited (now Willis Towers Watson PLC) covers the month of June 2001. The registrant is a global insurance broker providing risk management and advisory services, with expertise in construction, aerospace, marine, and energy sectors.
Key Financial Metrics
The filing announces an Initial Public Offering (IPO) rather than reporting periodic operating results.
- Offering Price: $13.50 per share.
- Shares Offered: 20,000,000 shares of common stock.
- Over-Allotment Option: Underwriters granted an option to purchase up to 3,000,000 additional shares.
- Expected Proceeds: Approximately $270 million (before out-of-pocket expenses).
- Trading Symbol: WSH on the New York Stock Exchange (commenced June 12, 2001).
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the period.
Material Changes
The primary material change is the company's transition to a publicly traded entity on the NYSE. Proceeds from the offering are designated to redeem preference shares of TA II Limited, repurchase senior subordinated notes of Willis North America, or both.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond standard legal disclaimers regarding the legality of the securities offer in various states. The document notes that the announcement does not constitute an offer to sell securities where such an offer would be unlawful prior to registration.
Investor Verification Checklist
- Verify the final number of shares issued, including any exercise of the 3,000,000 share over-allotment option.
- Confirm the actual net proceeds after deducting underwriting fees and out-of-pocket expenses.
- Review the specific allocation of proceeds between the redemption of TA II Limited preference shares and the repurchase of Willis North America notes.
- Obtain the full prospectus for detailed financial statements and risk factors not included in this summary.